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formation and protein oxidation against
fructose-induced protein glycation in vitro
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Background: Mesona chinensis Benth (Chinese Mesona), an economically significant agricultural plant, is the most
widely consumed as an herbal beverage in Southeast Asia and China. The objective of this study was to evaluate
the inhibitory activity of Mesona chinensis (MC) extract on the formation of advanced glycation end products (AGEs)
and protein oxidation in an in vitro model of fructose-mediated protein glycation.
Methods: The content of total polyphenolic compounds was measured by using Folin–Ciocalteu assay.
Antiglycation activity was determined using the formation of AGE fluorescence intensity, Nε-(carboxymethyl)lysine
(CML), the level of fructosamine, and the formation of amyloid cross β-structure. The protein oxidation was
examined using the level of protein carbonyl content and thiol group.
Results: Our results revealed that the content of total polyphenolic compound in MC extract was 212.4 ± 5.6 mg
gallic acid equivalents/g dried extract. MC extract (0.25-1.00 mg/mL) significantly inhibited the formation of
fluorescence AGEs in fructose-glycated bovine serum albumin (BSA) during 4 weeks of study. Furthermore, MC
extract also decreased the level of Nε-CML, fructosamine, and amyloid cross β-structure in fructose-glycated BSA.
While the total thiol group was elevated and the protein carbonyl content was decreased in BSA incubated with
fructose and MC extract.
Conclusions: The extract of MC inhibits fructose-mediated protein glycation and protein oxidation. This edible plant
could be a natural rich source of antiglycation agent for preventing AGE-mediated diabetic complication.
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Chronic hyperglycemia plays a vital role in the develop-
ment of long-term diabetic complications by increasing
non-enzymatic protein glycation and the gradual forma-
tion of advanced glycation end products (AGEs) in body
tissues [1]. Protein glycation causes marked changes in
the structural properties and stability that impair protein
function associated with the pathogenesis of age-related
diseases [2]. Consequently, the interaction of AGEs with
receptors for AGEs (RAGE) directly activates multiple
intracellular signaling, gene expression, and the secretory* Correspondence: sirichai.a@chula.ac.th
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article, unless otherwise stated.pro-inflammatory molecules accompanied by increasing
free radicals that contribute towards pathologic complica-
tions related to diabetes such as atherosclerosis, nephro-
pathy, peripheral neuropathy, retinopathy and cataract [3].
Aminoguanidine, a prototype therapeutic agent for inhi-
bition of AGE formation, has received the most interest
from a clinical trials perspective [4,5]. However, it may
have serious toxicity when administered for diabetic ne-
phropathy [5]. Therefore, there is considerable interest in
search of plant-based diets with antiglycation activity as
they may potentially inhibit AGE formation resulting in
delaying and preventing the onset of diabetic complica-
tions with minimal side effects [6-8].
Many studies have shown the beneficial effect of plant-
based diets for the inhibition of protein glycation in vitro
and in vivo [9,10]. Mesona chinensis Benth (ChineseCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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nomically important agricultural plant in Southeast Asia
and China [11]. This plant-based diet is the most widely
consumed as an herbal beverage and a gelatin-type dessert
(Grass jelly). In addition, it has been utilized in ancient folk
medicine for treatment of hypertension, diabetes, and liver
diseases [10]. The assessment of available nutrient status
has shown that M. chinensis (MC) includes 17 amino acids
(7 essential amino acids), carbohydrate, fat, fiber, poly-
phenols, and flavonoids [12,13]. However, there were no
reports in the scientific literature on antiglycation
activity of MC. Hence, the aim of this study were carried
out to investigate the inhibitory effects of MC against
fructose-mediated non-enzymatic glycation and oxidation-
dependent damages to BSA. These results reported herein
support the notion that this plant-based diet could be a
new avenue for treatment and prevention of protein glyca-
tion and related diseases conditions.
Methods
Chemicals
Bovine serum albumin (BSA, fraction V), aminoguanidine
hydrochloride (AG), nitroblue tetrazolium (NBT), 1-deoxy-
1-morpholino-D-fructose (1-DMF), guanidine hydrochlo-
ride, congo red, 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB)
and L-cysteine were purchased from Sigma-Aldrich Co.
(St. Louis, MO, USA). D-fructose and 2,4-dinitrophenyl
hydrazine (DNPH) were purchased from Ajax Finechem
(Taren Point, Australia). Trichloroacetic acid (TCA) was
purchased from Merck (Darmstadt, FR, Germany). Oxi-
Select™ Nε-(carboxymethyl) lysine (CML) ELISA kit was
obtained from Cell Biolabs (San Diego, CA, USA). All
other chemicals and solvents used in this study were of
analytical grade.
Plant preparation and extraction
The dried whole plants were purchased from a specific
herbal drugstore, Bangkok, Thailand. The plant has been
authenticated at the Professor Kasin Suvatabhandhu
Herbarium, Department of Botany, Chulalongkorn
University, Thailand, Voucher specimen: A013637
(BCU). The dried plants (300 g) were boiled in distilled
water (4 L) at 90°C for 4 hours. After boiling, the resi-
due of plant was filtered with a colander. The aqueous
extraction was dried using a spray dryer SD-100 (Eyela
world, Tokyo Rikakikai Co., LTD, Japan). The condition
of spray dryer was inlet temperature 178-180°C, outlet
temperature 85-95°C, blower (0.80-0.90) m3/min, and
atomizing at 90 kPa. The powder extract was kept in a
dry place.
Measurement of total polyphenolic content
The content of total polyphenolic compounds in the ex-
tract was determined using the Folin-Ciocalteu’s phenolreagent [14]. The content of total polyphenolic compounds
was expressed as mg gallic acid equivalents/g dried extract.
In vitro glycation of bovine serum albumin
Glycated BSA was done according to a previously pub-
lished method [15]. Briefly, 10 mg/mL BSA (0.50 mL)
was incubated with 0.46 mL of 500 mM fructose in
100 mM phosphate buffered-saline (pH 7.4) containing
0.02% sodium azide at 37°C for 4 weeks. Before incuba-
tion, 0.04 mL of MC extract (final concentration: 0.25-
1.00 mg/mL) and AG (final concentration: 1.00 mg/mL)
were added into the reaction mixtures. The formation of
fluorescent AGEs was measured by using a spectrofluo-
rometer. The fluorescent intensity was measured at an ex-
citation wavelength of 355 nm and emission wavelength
of 460 nm. The percentage of fluorescent AGE formation
was calculated as follows:
Inhibition of fluorescent AGEs %ð Þ
¼ FC−FCBð Þ− FS−FSBð Þ= FC−FCBð Þ½  x100
Where FC and FCB were the fluorescent intensity of
control with fructose and blank of control without fruc-
tose, FS and FSB were the fluorescent intensity of sample
with fructose and blank of sample without fructose.
The concentration of non-fluorescent AGEs (Nε-
(carboxymethyl) lysine, CML), a major non-fluorescent
AGEs structure, was measured by using enzyme linked
immunosorbant assay (ELISA) kit according to the manu-
facturer’s protocol. The concentration of Nε-CML was cal-
culated by using a standard curve of Nε-CML-BSA.
Determination of fructosamine
The level of fructosamine was measured by using nitroblue-
tetrazolium (NBT) dye according to a previous published
method [16]. Briefly, glycated BSA (10 μL) was incubated
with 0.5 mM NBT (90 μL) in 100 mM carbonate buffer,
pH 10.4 at 37°C. The absorbance was recorded at 530 nm.
The level of fructosamine was calculated by using the dif-
ferent absorption at the time point of 10 and 15 min. The
level of fructosamine was calculated from a standard curve
(0.31-5.0 mM) prepared using 1-deoxy-1-morpholino-
fructose (1-DMF).
Determination of protein aggregation
Amyloid cross β-structure, a common marker for protein
aggregation was measured by using a congo red assay
according to a previous published method with minor
modifications [17]. Briefly, the glycated BSA (50 μL) was
incubated with 50 μL of 100 μM congo red in 10% (v/v)
ethanol/PBS for 20 min at 25°C. The absorbance was mea-
sured at 530 nm.
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Protein thiol groups were measured according to a pre-
vious published method with minor modifications [18].
In brief, glycated BSA (10 μL) was reacted with 90 μL of
5 mM 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) in
100 mM phosphate buffered-saline (pH 7.4) at room
temperature for 15 min. Thereafter, the absorbance was
measured at 412 nm. The level of protein thiol groups
was calculated from a standard curve (0.015-0.50 mM)
prepared using L-cysteine. The results were expressed
as nmol L-cysteine/mg protein.
Determination of protein carbonyl contents
The protein carbonyl contents were measured according
to a previous published method with minor modifications
[18]. In brief, glycated BSA (0.10 mL) was incubated with
0.40 mL of 10 mM 2,4-dinitrophenylhydrazine (DNPH) in
2.5 M HCl at room temperature for 60 min. Subsequently,
glycated BSA was precipitated by 0.50 mL of 20% (w/v)
trichloroacetic acid (TCA), left on ice for 5 min, and cen-
trifuged at 10,000 g at 4°C for 10 min. The pellet was
washed three times using 1:1 (v/v) ethanol:ethyl acetate
mixture (1 mL). The final pellet was dissolved in 6 M
guanidine hydrochloride (0.25 mL). The absorbance was
recorded at 370 nm. The level of protein carbonyl con-
tents was calculated by using an absorption coefficient of
22,000 M−1 cm−1. The results were expressed as nmol
carbonyls/mg protein.
Statistical analysis
Data were expressed as mean ± standard error of mean
(SEM) (n = 3). The statistical significance of the results
was evaluated by using one-way ANOVA. The Tukey’s
HSD test was used to analyze the statistically significantFigure 1 The effects of MC extract on the formation of fluorescent AG
mean ± SEM (n = 3). *P < 0.05 when compared to BSA/fructose at the samedifferences of mean. P < 0.05 was considered to be statis-
tically significant.Results
Phytochemical analysis of MC extract
The present data showed that the total polyphenolic
content of MC extract was 212.4 ± 5.6 mg gallic acid
equivalents/g dried extract.The effects of MC extract on the formation of
fluorescence AGEs and Nε-CML
As shown in Figure 1, the formation of AGEs was observed
weekly by the measurement of increasing fluorescent in-
tensity in fructose-glycated BSA. The significant increase
in fluorescent intensity in BSA incubated with fructose was
seen during 4 weeks of the incubation. The results demon-
strated that addition of MC extract (0.25-1.00 mg/mL) into
the solution significantly reduced the formation of fluores-
cent AGE in a concentration-dependent manner through-
out the study period. Similar to the effect of MC (1.00 mg/
mL), a significant inhibition of fluorescent AGEs was ob-
served in fructose-glycated BSA plus AG (1.00 mg/mL).
The percentage inhibition of MC (0.25-1.00 mg/mL) is
shown in Table 1. At week 4 of incubation, the percentage
inhibition of MC extract (0.25-1.00 mg/mL) was approxi-
mately 39.60-59.42%, whereas AG (1.00 mg/mL) decreased
the formation of fluorescence AGEs by 90.84%. The
results indicated that MC extract had 1.5-times less
potency than AG.
The levels of Nε-CML, a biomarker for the formation
of non-fluorescent AGE are shown in Figure 2. Accord-
ing to the results, MC extract (1.00 mg/mL) and AG
(1.00 mg/mL) decreased 26.0% and 59.7% of Nε-CMLEs in BSA incubated with fructose. Each value represents the
week.
Table 1 The percentage inhibition of MC extract on the
formation of fluorescent AGEs during the experimental
period
Samples % Inhibition
Week 1 Week 2 Week 3 Week 4
Fr/BSA/MC
0.25 mg/mL
59.65 ± 3.22 43.14 ± 1.66 30.78 ± 3.01 39.60 ± 2.96
Fr/BSA/MC
0.50 mg/mL
65.80 ± 1.27 49.44 ± 5.04 40.81 ± 2.39 49.61 ± 1.18
Fr/BSA/MC
1.00 mg/mL
81.39 ± 1.23 53.43 ± 2.40 50.83 ± 2.85 59.42± 1.78
Fr/BSA/AG
1.00 mg/mL
86.81 ± 0.36 88.27 ± 0.35 89.51± 0.27 90.84 ± 0.88
Data are expressed as mean ± SEM, n = 3 (Fr: fructose; MC: Mesona chinensis;
AG: aminoguanidine).
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ting that MC extract had 2.3-times less potency than AG.
The effects of MC extract on the level of fructosamine
The effects of MC extract on the level of fructosamine
are presented in Figure 3. The level of fructosamine in
fructose-glycated BSA markedly increased throughout
4 weeks of the experiment. The increasing level of fruc-
tosamine was attenuated by MC extract during 4 weeks
of study. In comparison at the end of study, the percentage
inhibition of MC extract (0.25-1.00 mg/mL) was approxi-
mately 58.6-63.3%, whereas AG (1.00 mg/mL decreased
the level of fructosamine by 40.6%.
The effects of MC extract on the level of amyloid cross-β
structure
Congo red assay is generally used to measure the amount
of a protein modification called amyloid cross-β structureFigure 2 The effects of MC extract on the level of Nε-(carboxymethyl)
incubation. Each value represents the mean ± SEM (n = 3). *P < 0.05 whenin glycated BSA. As shown in Figure 4, BSA incubated
with fructose elevated the level of amyloid cross-β con-
formation throughout 4 weeks of experimental period. In
the meanwhile, fructose-glycated BSA incubated with MC
extract (0.25-1.00 mg/mL) significantly attenuated an in-
crease in the level of amyloid cross-β structure. At 4 week
of incubation, MC extract at concentrations of 0.25-
1.00 mg/mL reduced the level of amyloid cross-β struc-
ture in a concentration-dependent manner (8.1%, 9.7%
and 10.3%) Similarly, a significant decrease in the level
of amyloid cross-β structure (10.1%) was observed in
the presence of AG (1 mg/mL) at week 4 of incubation.
The effects of MC on protein oxidation
In order to access the protein oxidation mediated by gly-
cation process, the level of carbonyl content and thiol
groups was used for determination. As shown in Figure 5,
the carbonyl content of fructose-glycated BSA was signifi-
cantly increased during the experimental period, whereas
MC extract (0.25-1.00 mg/mL) significantly suppressed
an increase in protein carbonyl content of fructose-
glycated BSA. When comparing with fructose-glycated
BSA at week 4, the percentage reduction of carbonyl
content by MC extract (0.50-1.00 mg/mL) ranged from
36.2 to 46.7%. A significant reduction of protein car-
bonyl content (24.4%) was seen in the presence of AG
(1 mg/mL) at the same week.
The effects of MC extract on the oxidation of protein
thiols are presented in Figure 6. When BSA was incubated
with fructose, the level of thiol groups had continuously
declined throughout the experimental period. Interest-
ingly, there was a significant increase in the level of thiol
groups after addition of MC extract (0.25-1.00 mg/mL) as
well as AG (1.00 mg/mL). The findings showed that thelysine (CML) in BSA incubated with fructose after 4 weeks of
compared to BSA/fructose.
Figure 3 The effects of MC extract on the level of fructosamine in BSA incubated with fructose. Each value represents the mean ± SEM
(n = 3). *P < 0.05 when compared to BSA/fructose at the same week.
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46.2 to 64.1%, whereas AG (1 mg/mL) significantly pre-
vented (57.9%) the depletion of protein thiol groups at the
week 4 of incubation. According to the results, MC ex-
tract is more potent in the reduction of fructose-induced
protein oxidation than AG.
Discussion
Glycated proteins are commonly formed by a non-
enzymatic reaction between the interaction of reducing
sugars (fructose and glucose) and amino group of protein
through a nucleophilic addition with formation of Schiff
bases [1]. The unstable Schiff bases further rearrange toFigure 4 The effects of MC extract on the formation of amyloid cross
the mean ± SEM (n = 3). *P < 0.05 when compared to BSA/fructose at the sproduce the formation of reversible Amadori products
(such as fructosamine). Subsequently, the Amadori prod-
ucts further form cross-linked structures termed AGEs
which can be classified into two major groups: fluorescent
and crosslinking structures (pentosidine, crosslines, and
imidazolones) and non-fluorescent and non-crosslinking
structures (Nε-CML). The formation of AGEs occurs
through multiple processes related in the part to gene-
rate reactive oxygen species (ROS). It is noteworthy that
the superoxide anion productions (1,2- and 2,3-enolization
of the Schiff's base and oxidation of the enolate anion) are
particularly generated from early glycation products
[19,20]. Consequently, reactive oxygen species-mediated-β structure in BSA incubated with fructose. Each value represents
ame week.
Figure 5 The effects of MC extract on the protein carbonyl content in BSA incubated with fructose. Each value represents the mean ±
SEM (n = 3). *P < 0.05 when compared to BSA/fructose at the same week.
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short-chain carbohydrate intermediates, which then alters
sequentially with lysine and arginine residues to produce
AGEs [19,20]. Currently, the possible anti-glycation me-
chanisms have been proposed such as breaking the cross-
linking structures in the formed AGEs, blocking the
carbonyl or dicarbonyl groups in reducing sugars, Schiff
bases or Amadori products, and inhibiting the forma-
tion of late-stage Amadori products [21]. It has revealed
that aminoguanidine acts as a carbonyl trapping agent
by forming guanidine-dicarbonyl adducts, thereby redu-
cing the numbers of free carbonyl groups in reducing
sugars during the early stages of glycation [21,22].Figure 6 The effects of MC extract on the level of thiol group in BSA
(n = 3). *P < 0.05 when compared to BSA/fructose at the same week.There has been research into the role of dietary fructose
in the development of diabetes complications. Excessive
fructose consumption has been linked to the development
of metabolic syndromes and obesity [23]. It is well docu-
mented that long-term fructose consumption leads to
glycoxidation and generation of ROS causing oxidative
damage and cellular dysfunction that accompany the
aging process [24]. The concentration of fructose in hu-
man tissues and fluids is generally much lower than that
of glucose. Under hyperglycemic conditions, fructose can
be synthesized by oxidation of sorbitol through a reaction
catalyzed by polyol dehydrogenase. Ocular lens are one
of specific organs where the sorbitol pathway is active,incubated with fructose. Each value represents the mean ± SEM
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culation. These results lead to accelerate the reaction
between fructose and protein, giving AGE formation
and accumulation in len proteins. From previous studies
comparing the reactivity of glucose and fructose with pro-
teins at physiological temperature and the equal concentra-
tion, a faster accumulation of protein-bound fluorescence
and cross-linking products was from fructose [18,25]. In
addition, fructose has been shown to be more rapidly pro-
duced dicarbonyl compounds and hydroxyl radicals by aut-
oxidation, compared to glucose [26]. Currently, a study has
been published on the site specificity of modification of ly-
sine residues and total of Nε-CML in BSA incubated with
fructose and glucose. The major site of modification by
fructose, like glucose, is Lysine-524 and 31 and 76% loss of
the corresponding unmodified tryptic peptide is observed
at Gln525-Lys533 [22]. The fructose-modified BSA has the
yield of Nε-CML being up to 17-fold higher than glucose-
modified BSA.
In a present study, we investigated the influence of
MC extract on the formation of total AGEs. The results
showed that MC extract efficiently inhibited fluorescent
and non-fluorescent AGE formation. Furthermore, it also
reduced the level of fructosamine and amyloid cross β-
structure in fructose-glycated BSA. A significant increase
of protein carbonyl content and oxidation of thiols in BSA
were seen when the protein was glycated by fructose.
When MC extract was added to the same systems, it sig-
nificantly suppressed these processes. Our findings indi-
cate that MC extract has high content of polyphenolic
compounds. Several major mechanisms by which poly-
phenols block the carbonyl group in reducing sugars
and break the crosslinking structure in the formed
AGEs have recently been proposed for antiglycation ac-
tivity [21]. The reduction of free radical generation by
antioxidant activity of polyphenols may highlight other
mechanisms for the prevention of AGE formation [21].
Recent studies carried out over the past few years have
shown that polyphenolic compounds from the edible
plants may play a protective role against monosaccharide-
induced protein glycation [27,28]. The earlier studies re-
port a strong correlation between the polyphenolic con-
tent in the tested plant extracts and the ability to inhibit
protein glycation [29,30]. Our previous studies have
previously shown the inhibitory activity on edible plant
extracts containing polyphenolic compounds [7,31]. Ac-
cording to the results obtained, we addressed the hy-
pothesis that polyphenolic compounds in the extract
may be a major contributor to inhibit the formation of
AGEs. However, certain active biological constituents of
MC extract remain unknown. To prove this hypothesis,
separation and characterization of polyphenolic com-
pound in MC extract using HPLC-MS are required for
further study.In general, protein glycation can directly affect the for-
mation of protein aggregation. The insoluble aggregates
can form amyloid cross β-structure leading to alter pro-
tein structure and stability [17]. The long-term accumula-
tion of amyloid cross β-structures in the tissues may cause
the progression of pancreatic islet amyloidosis which dir-
ectly destroys β-cell and impairs insulin secretion [32].
The present findings demonstrate that MC extract re-
duces the formation of amyloid cross β-structures in BSA
in vitro. This beneficial effect might help reduce the risk
of developing diabetes complications.
Glycation with fructose rapidly induces protein oxida-
tion and consequently alters the structure of BSA associ-
ated with modifications of its biological properties. In
particular, the thiol group of Cys residues is particularly
prone to oxidative attack by free radical damage to pro-
teins, as it is known that the formation of disulfide bonds
occurs in protein aggregation and results in the loss of en-
zymatic activity [33]. The direct oxidation of amino acid
(Lys, Arg, Thr) or secondary reaction of amino acid resi-
dues (Cys and His) with reactive carbonyl compounds can
produce the formation of protein carbonyl derivatives
[34]. Our findings are consistent with previous literatures
indicating that fructose-induced glycation increased pro-
tein oxidation as evidenced by decreased thiol group and
increased protein carbonyl content [16]. The present find-
ings suggest that the MC has shown remarkable potential
in protecting the protein thiols and reducing the protein
carbonyl content. There is a well-documented evidence
for antioxidant activity of Mesona procumbens Hemsley
(Hsian-tsao), the same genus of M. chinensis [35]. The
crude extract of M. procumbens leaf gum has also shown
a remarkably high scavenging activity toward chemically
generated reactive oxygen species [36]. Recent studies in
our findings have shown the antioxidant activity of MC
extract tested by different methods [37]. The findings indi-
cated that MC extract had 7-times less potency than as-
corbic acid. On the DPPH assay, MC extract had 7-times
less potency than ascorbic acid. In the meanwhile, MC ex-
tract had 3-times and 3.6-times less potency of hydroxyl
and superoxide radical scavenging activity than trolox, re-
spectively. According to the abovementioned antiglycation
mechanisms, MC extract may inhibit AGE formation by
scavenging free radicals formed in vitro by auto-oxidation
of sugars and/or oxidative degradation of Amadori pro-
ducts. Most antiglycation agents with antioxidant activity
from the edible plants have been reported to possess poly-
phenolic compounds [21,28]. It has revealed that the in-
hibitory activity of polyphenols against protein glycation
was strongly related to their scavenging effect on free
radicals derived from the glycoxidation process [38]. Ac-
cording to many supporting documents, it can be as-
sumed that polyphenolic compounds in MC extract may
contribute to the antioxidant activity and antiglycation.
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MC extract has potent inhibitory effects on fructose-
induced protein glycation and oxidation damage in BSA.
MC extract with high antiglycation activity may offer
remarkable prospects for the preventive treatment of
AGE-mediated diabetic complications. For these reasons,
further studies should focus on the outcome of investiga-
ting effects in animal models.
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